维普期刊资源整合服务平台（V6.5）

33篇 您的检索式：作者名="Gast MC"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Comparing the old and new generation SELDI-TOF MS : implications for serum protein profiling 显示文摘	Gast MC Engwegen JY Schellens JH	2008	BMC Med Genomics2008，1，：	1
2	Validation of previously identified serum biomarkers for breast cancer with SELDITOF MS:a case control study显示文摘	van Winden AW Gast MC Beijnen JH		0，，：	1
3	Clinical proteomics :Searching for better turnout markers with SELDI -TOF mass spectrometry显示文摘	Engwegen JY Gast MC Schellens JH		Trends Pharmacol Sci0，27，5：	1
4	Postoperative serum proteomie profiles May predict recurrence-free sur- vival in high-risk primary breast Cancer显示文摘	Gast MC Zapatka M van Tinteren H	2011	J Cancer Res Clin Oncol2011，137，12：	1
5	Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry 显示文摘	Engwegen JY Gast MC Schellens JH	2006	Trends Pharmacol Sci2006，27，5：	1
6	Postoperative serum proteomic profiles may predict recurrence-free survival in high-risk primary breast cancer 显示文摘	Gast MC Zapatka M Tinteren H	2011	J Cancer Res Clin Onco12011，137，12：	1
7	Clinical proteomics:searching for better tumour markers with SELDI-TOF mass spectrometry显示文摘	Engwegen JY Gast MC Schellens JH	2006	Trends Pharmacol Sci2006，27，5：	1
8	clinical proteomics: searching for better tumor marker with SELDI-TOF mass spectrome- try显示文摘	Engwegen JY Gast MC Schellens JH	2006	Trends PharmacolSci2006，27，5：	1
9	Clinical proteomics:searching for better tumour markers with SELDI-TOF mass spectrometry显示文摘	Engwegen JY Gast MC Schelens JH	2006	Trends Pharmacol Sci2006，27，5：	1
10	Clinical proteomics:searching for better tumour markers with SELDI-TOF mass spectrometry显示文摘	Engwegen JY Gast MC Schellens JH	2006	Trends Pharmacol Sci2006，27，5：	1
11	Comparing the old and new generation SELDI-TOF MS:implications for serum protein profiling显示文摘	Gast MC Engwegen JY Schellens JH		0，，：	1
12	Detection of breast cancer by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry tissue and serum protein profiling显示文摘	Gast MC van Dulken EJ van Loenen TK	2009	Int J Biol Markers2009，24，3：	1
13	Haptoglobin phenotype is not a predictor of recurrence free survival in high-risk primary breast cancer patients显示文摘	Gast MC van Tinteren H Bontenbal M		0，，：	1
14	Validation of previously identified serum biomarkers for breast cancer with SELDI-TOF MS:a case control study显示文摘	van Winden AW Gast MC Beijnen JH	2009	BMC Med Genomics2009，2，：	1
15	Validation of previously identified serum biomarkers for breast cancer with SELDITOF MS:a case control study显示文摘	van Winden AW Gast MC Beijnen JH		0，，：	1
16	Detection of breast cancer by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry tissue and serum protein profiling 显示文摘	Gast MC van Dulken EJ Van Loenen TK	2009	Int J Biol Markers2009，24，3：	1
17	Clinical proteomics : searching for better tumour markers with SELEI-TOF mass spectrometry 显示文摘	Engwegen JY Gast MC Schellens JH	2006	Trends Pharmacol Sci2006，27，5：	1
18	Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spee trometry显示文摘	Engwegen JY Gast MC Schellens JH	2006	Trends Pharmacol Sci2006，27，5：	1
19	Clinical proteomics: Searching for better tumour markers with SELDI-TOF mass spectrometry 显示文摘	Engwegen JY Gast MC Schellens JH Beijnen JH	2006	Trends Pharmacol Sci2006，27，5：	1
20	Detection of breast cancer by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry tissue and serum protein profiling 显示文摘	Gast MC van Dulken EJ van Loenen TK Kingma-Vegter F Westerga J Flohil CC	2009	Int J Biol Markers2009，24，3：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示